Oscar Health is trading 4.2% down at $30.26 as investors take profits following a strong advance ahead of its second-quarter 2026 earnings release.
- The move follows a 4.2% gain to $31.82 on July 13, 2026, as investors positioned for the August 6, 2026, Q2 earnings call.
- Current price action suggests profit-taking and consolidation rather than a new negative company-specific development.